Cerebral Blood Flow and Dementia in Parkinson's Disease

Regional cerebral blood flow (CBF) was examined in 27 patients with Parkinson's disease using single-photon emission computed tomography and N-isopropyl-p-[123I]iodoamphetamine as a tracer. Their CBF pattern was compared with that of seven patients with Alzheimer's disease and nine age-matched neurologically normal controls. Tracer activity was determined in seven bilateral cerebellar, cortical, and subcortical regions and was expressed as the ratio of activity in each region to the mean tracer activity in the cerebellar region. Nineteen patients with nondemented Parkinson's disease showed significantly decreased tracer activity ratio in the frontal and temporal cortices, basal ganglia, and thalamus compared with that in controls. The eight demented Parkinson's disease patients showed significantly decreased tracer activity ratio in the temporal and parietal cortices compared with the patients without dementia, and demonstrated CBF pattern similar to that of patients with Alzheimer's disease. These findings suggest that in patients with Parkinson's disease, the mechanism of CBF reduction of the frontal cortical region differs from that in the temporoparietal cortical region and support the concept that Parkinson's disease and Alzheimer's disease may overlap in some patients. (J Geriatr Psychiatry Neurol 1991;4:194-203).

[1]  O. Hornykiewicz,et al.  Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid ([3H]GABA) binding in the human brain: Alterations in Parkinson's disease , 1977, Brain Research.

[2]  Keith A. Johnson,et al.  Cerebral perfusion imaging in Alzheimer??s disease: use of single photon emission computed tomography and iofetamine hydrochloride I 123 , 1987 .

[3]  E. Melamed,et al.  Cerebral blood flow and cognitive impairment in Parkinson's disease , 1985, Neurology.

[4]  T Jones,et al.  Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. , 1981, Brain : a journal of neurology.

[5]  Marcus E. Raichle,et al.  Regional blood flow in herniparkinsonism , 1985, Neurology.

[6]  D. Benson,et al.  Subcortical Dementia: Review of an Emerging Concept , 1984 .

[7]  W. Gibb,et al.  Dementia and Parkinson's Disease , 1989, British Journal of Psychiatry.

[8]  U. Roessmann,et al.  Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations , 1980, Annals of neurology.

[9]  G. Paulson,et al.  Cortical vs subcortical dementia. Neuropsychological differences. , 1986, Archives of neurology.

[10]  J Marshall,et al.  Cerebral blood flow in dementia. , 1975, Archives of neurology.

[11]  M. Dam,et al.  [99mTc]-HM-PAO SPECT in Parkinson's Disease , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  E. Metter,et al.  Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  R. S. J. Frackowiak,et al.  REGIONAL CEREBRAL OXYGEN SUPPLY AND UTILIZATION IN DEMENTIAA CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN-15 AND POSITRON TOMOGRAPHY A CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN - 15 AND POSITRON TOMOHRAPHY , 1981 .

[14]  D L Price,et al.  Basal forebrain neurons in the dementia of Parkinson disease , 1983, Annals of neurology.

[15]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[16]  M. D. de Leon,et al.  Elevated Cerebellar Glucose Metabolism in Microvascular White Matter Disease: Normal Aging and Alzheimer's Disease , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  J. Barrio,et al.  Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  Y. Agid,et al.  Biochemical substrates of mental disturbances in Parkinson's disease. , 1984, Advances in neurology.

[19]  T Jones,et al.  Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease , 1985, Neurology.

[20]  E. Perry,et al.  Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases , 1983, Journal of the Neurological Sciences.

[21]  A. Kidman,et al.  In vitro skeletal muscle protein and RNA incorporation in neuromuscular disease , 1982, Journal of the Neurological Sciences.

[22]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[23]  D W Palmer,et al.  Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging. , 1989, Radiology.

[24]  B. Holman,et al.  Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. , 1987, Archives of neurology.

[25]  R. Gur,et al.  Dementia of Parkinson's Disease and Alzheimer's Disease: Is There a Difference? , 1986, Journal of The American Geriatrics Society.

[26]  P. Mcgeer,et al.  Crossed cerebellar and uncrossed basal ganglia and thalarnic diaschisis in Alzheimer's disease , 1989, Neurology.

[27]  P. Dupui,et al.  Cerebral Blood Flow Studied by Xenon-133 Inhalation Technique in Parkinsonism: Loss of Hyperfrontal Pattern , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  R. L. Rogers,et al.  Xenon Contrast CT‐CBF Measurements in Parkinsonism and Normal Aging , 1985, Journal of the American Geriatrics Society.

[29]  L. Henriksen,et al.  Regional cerebral blood flow in hemiparkinsonian patients. Emission computerized tomography of inhaled 133Xenon before and after levodopa , 1985, Acta neurologica Scandinavica.

[30]  W. Oldendorf,et al.  N-isopropyl-[123I] p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  B. L. Beattie,et al.  Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[32]  R. Roth,et al.  Pharmacology of mesocortical dopamine neurons. , 1983, Pharmacological reviews.

[33]  F E Bloom,et al.  Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. , 1978, Annual review of neuroscience.

[34]  M E Raichle,et al.  Regional blood flow in hemiparkinsonism. , 1985, Neurology.

[35]  K. Ebmeier,et al.  Cerebral blood flow measured by SPECT as a diagnostic tool in the study of dementia , 1989, Psychiatry Research.

[36]  P. Sharp,et al.  Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  P. Seeman,et al.  Dopamine D2 receptor density in parkinsonian brain is constant for duration of disease, age, and duration of L-dopa therapy. , 1987, Advances in neurology.

[38]  R. L. Rogers,et al.  Effects of Aging on Cerebral Blood Flow in Dementia , 1984, Journal of the American Geriatrics Society.

[39]  F. Boiler.  Mental status of patients with parkinson disease , 1980 .

[40]  Y. Agid,et al.  CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients , 1982, Brain Research.

[41]  I. Mena,et al.  Temporal-parietal hypoperfusion with single-photon emission computerized tomography in conditions other than alzheimer’s disease , 1990 .

[42]  J. Fleiss,et al.  Some Statistical Methods Useful in Circulation Research , 1980, Circulation research.

[43]  Y. Agid,et al.  Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia , 1982, Brain Research.

[44]  R Harrop,et al.  Cerebral Glucose Metabolism in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[45]  A. Hakim,et al.  Dementia in Parkinson disease , 1979, Neurology.

[46]  M. Kupersmith,et al.  Dementia in Parkinson disease , 1979, Annals of neurology.

[47]  D. Calne,et al.  Is "Parkinson's disease" one disease? , 1989, Journal of neurology, neurosurgery, and psychiatry.

[48]  O. Lopez,et al.  Diagnosis of dementia , 1989, Neurology.

[49]  U. Rinne,et al.  Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor. , 1973, Archives of neurology.

[50]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[51]  A. Hirano,et al.  AN ATLAS OF THE HUMAN BRAIN FOR COMPUTERIZED TOMOGRAPHY. , 1978 .

[52]  J. Morris,et al.  Validation of clinical diagnostic criteria for Alzheimer's disease , 1988, Annals of neurology.

[53]  R. Mayeux,et al.  Is "subcortical dementia" a recognizable clinical entity? , 1983, Annals of neurology.